Alnylam Pharmaceuticals Surges to 279th in Trading Volume with $354 Million in Shares Exchanged

On May 15, 2025, Alnylam Pharmaceuticals, Inc. (ALNY) saw a significant surge in trading volume, with a total of $354 million in shares exchanged, marking an 89.79% increase from the previous day. This surge placed ALNY at the 279th position in terms of trading volume for the day. The stock price of ALNY also rose by 5.92%, marking the second consecutive day of gains, with a total increase of 6.20% over the past two days.

Alnylam Pharmaceuticals, Inc. recently presented at the BofA Securities 2025 Healthcare Conference. The company's participation in this event is expected to provide valuable insights into its strategic direction and future prospects, potentially influencing investor sentiment and stock performance.

Alnylam Pharmaceuticals, Inc. is scheduled to webcast a presentation at the BofA Securities 2025 Health Care Conference. This event is likely to attract significant attention from investors and analysts, as it will offer a platform for the company to discuss its latest developments and future plans.